These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 12458343

  • 1. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
    Yahata H, Kobayashi H, Kamura T, Amada S, Hirakawa T, Kohno K, Kuwano M, Nakano H.
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):621-6. PubMed ID: 12458343
    [Abstract] [Full Text] [Related]

  • 2. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
    Ohga T, Koike K, Ono M, Makino Y, Itagaki Y, Tanimoto M, Kuwano M, Kohno K.
    Cancer Res; 1996 Sep 15; 56(18):4224-8. PubMed ID: 8797596
    [Abstract] [Full Text] [Related]

  • 3. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
    Oda Y, Sakamoto A, Shinohara N, Ohga T, Uchiumi T, Kohno K, Tsuneyoshi M, Kuwano M, Iwamoto Y.
    Clin Cancer Res; 1998 Sep 15; 4(9):2273-7. PubMed ID: 9748149
    [Abstract] [Full Text] [Related]

  • 4. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.
    Ise T, Nagatani G, Imamura T, Kato K, Takano H, Nomoto M, Izumi H, Ohmori H, Okamoto T, Ohga T, Uchiumi T, Kuwano M, Kohno K.
    Cancer Res; 1999 Jan 15; 59(2):342-6. PubMed ID: 9927044
    [Abstract] [Full Text] [Related]

  • 5. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
    Gu C, Oyama T, Osaki T, Kohno K, Yasumoto K.
    Anticancer Res; 2001 Jan 15; 21(4A):2357-62. PubMed ID: 11724293
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.
    Nagatani G, Nomoto M, Takano H, Ise T, Kato K, Imamura T, Izumi H, Makishima K, Kohno K.
    Cancer Res; 2001 Feb 15; 61(4):1592-7. PubMed ID: 11245470
    [Abstract] [Full Text] [Related]

  • 7. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.
    Shibahara K, Sugio K, Osaki T, Uchiumi T, Maehara Y, Kohno K, Yasumoto K, Sugimachi K, Kuwano M.
    Clin Cancer Res; 2001 Oct 15; 7(10):3151-5. PubMed ID: 11595709
    [Abstract] [Full Text] [Related]

  • 8. Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients.
    Song J, Shih IeM, Salani R, Chan DW, Zhang Z.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6842-9. PubMed ID: 17982121
    [Abstract] [Full Text] [Related]

  • 9. [Molecular mechanism of the stress induction of MDR1 gene].
    Kohno K.
    Nihon Rinsho; 1997 May 15; 55(5):1054-8. PubMed ID: 9155152
    [Abstract] [Full Text] [Related]

  • 10. The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.
    Guay D, Evoy AA, Paquet E, Garand C, Bachvarova M, Bachvarov D, Lebel M.
    Int J Biochem Cell Biol; 2008 May 15; 40(11):2492-507. PubMed ID: 18571458
    [Abstract] [Full Text] [Related]

  • 11. Nuclear localization of Y-box factor YB1 requires wild-type p53.
    Zhang YF, Homer C, Edwards SJ, Hananeia L, Lasham A, Royds J, Sheard P, Braithwaite AW.
    Oncogene; 2003 May 08; 22(18):2782-94. PubMed ID: 12743601
    [Abstract] [Full Text] [Related]

  • 12. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
    Fujita T, Ito K, Izumi H, Kimura M, Sano M, Nakagomi H, Maeno K, Hama Y, Shingu K, Tsuchiya S, Kohno K, Fujimori M.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8837-44. PubMed ID: 16361573
    [Abstract] [Full Text] [Related]

  • 13. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W, Ke S, Chen G, Gao Q, Wu S, Wang S, Zhou J, Yang X, Lu Y, Ma D.
    Oncol Rep; 2004 Dec 15; 12(6):1365-70. PubMed ID: 15547764
    [Abstract] [Full Text] [Related]

  • 14. Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines.
    Bonovich M, Olive M, Reed E, O'Connell B, Vinson C.
    Cancer Gene Ther; 2002 Jan 15; 9(1):62-70. PubMed ID: 11916245
    [Abstract] [Full Text] [Related]

  • 15. Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer.
    Huang X, Ushijima K, Komai K, Takemoto Y, Motoshima S, Kamura T, Kohno K.
    Gynecol Oncol; 2004 May 15; 93(2):287-91. PubMed ID: 15099935
    [Abstract] [Full Text] [Related]

  • 16. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul 15; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

  • 17. The pleiotropic functions of the Y-box-binding protein, YB-1.
    Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M.
    Bioessays; 2003 Jul 15; 25(7):691-8. PubMed ID: 12815724
    [Abstract] [Full Text] [Related]

  • 18. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Fujii T, Kawahara A, Basaki Y, Hattori S, Nakashima K, Nakano K, Shirouzu K, Kohno K, Yanagawa T, Yamana H, Nishio K, Ono M, Kuwano M, Kage M.
    Cancer Res; 2008 Mar 01; 68(5):1504-12. PubMed ID: 18316615
    [Abstract] [Full Text] [Related]

  • 19. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
    de la Taille A, Rubin MA, Chen MW, Vacherot F, de Medina SG, Burchardt M, Buttyan R, Chopin D.
    Clin Cancer Res; 2003 May 01; 9(5):1801-7. PubMed ID: 12738737
    [Abstract] [Full Text] [Related]

  • 20. Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?
    Kamura T, Yahata H, Amada S, Ogawa S, Sonoda T, Kobayashi H, Mitsumoto M, Kohno K, Kuwano M, Nakano H.
    Cancer; 1999 Jun 01; 85(11):2450-4. PubMed ID: 10357417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.